Drug resistance is an important problem hindering malaria elimination in tropical areas. Point mutations in Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes confer resistance to antifolate drug, sulfadoxine-pyrimethamine (SP) while P. falciparum chloroquine-resistant transporter (Pfcrt) genes caused resistance to chloroquine (CQ). Decline in Pfdhfr/Pfdhps and Pfcrt mutations after withdrawal of SP and CQ has been reported. The aim of present study was to investigate the prevalence of Pfdhfr, Pfdhps, and Pfcrt mutation from 2 endemic areas of Thailand. All of 200 blood samples collected from western area (Thai-Myanmar) and southern area (Thai-Malaysian) contained multiple mutations in Pfdhfr and Pfdhps genes. The most prevalent haplotypes for Pfdhfr and Pfdhps were quadruple and double mutations, respectively. The quadruple and triple mutations of Pfdhfr and Pfdhps were common in western samples, whereas low frequency of triple and double mutations was found in southern samples, respectively. The Pfcrt 76T mutation was present in all samples examined. Malaria isolated from 2 different endemic regions of Thailand had high mutation rates in the Pfdhfr, Pfdhps, and Pfcrt genes. These findings highlighted the fixation of mutant alleles causing resistance of SP and CQ in this area. It is necessary to monitor the re-emergence of SP and CQ sensitive parasites in this area.
Citations
Citations to this article as recorded by
Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management Xyonane Segovia, Bhavya Srivastava, Sergio Serrato-Arroyo, Ashley Guerrero, Silvie Huijben Malaria Journal.2025;[Epub] CrossRef
The Impact of Plasmodium falciparum Adenosine Triphosphatase-6 Gene (PfATPase6) Mutations in Artemisinin Resistance Obafemi Yemisi Dorcas, Atokolo Austine Journal of Pure and Applied Microbiology.2025; 19(4): 2575. CrossRef
Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon Pacome V. K. Tchuenkam, Lesley N. Ngum, Innocent M. Ali, Jean Paul K. Chedjou, Akindeh M. Nji, Palmer M. Netongo, Randolph Ngwafor, Peter Thelma N. Niba, Calvino F. Tah, William D. Nana, Germaine Ekoyol, Jude D. Bigoga, Dorothy F. Ashu, Christopher B. Tum Wellcome Open Research.2024; 9: 323. CrossRef
Exploring the Recent Pioneering Developments of Small Molecules in Antimalarial Drug Armamentarium: A Chemistry Prospective Appraisal Tameika Bagratee, Ritika Prawlall, Thabani Ndlovu, Sinqobile Sibisi, Sisa Ndadane, Baji Baba Shaik, Mahesh B. Palkar, Raghavachary Gampa, Rajshekhar Karpoormath Chemistry & Biodiversity.2024;[Epub] CrossRef
In vitro
efficacy of next-generation dihydrotriazines and biguanides against babesiosis and malaria parasites
Pratap Vydyam, Meenal Chand, Shalev Gihaz, Isaline Renard, Gavin D. Heffernan, Laura R. Jacobus, David P. Jacobus, Kurt W. Saionz, Raju Shah, Hong-Ming Shieh, Jacek Terpinski, Wenyi Zhao, Emmanuel Cornillot, Choukri Ben Mamoun, Audrey Odom John Antimicrobial Agents and Chemotherapy.2024;[Epub] CrossRef
Antimalarial drug sulfadoxine induces gametocytogenesis in Plasmodium berghei Wihda Aisarul Azmi, Andita Fitri Mutiara Rizki, Achmad Shidiq, Yenny Djuardi, I Made Artika, Josephine Elizabeth Siregar Malaria Journal.2024;[Epub] CrossRef
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012–2022 Ruimin Zhou, Suhua Li, Penghui Ji, Shucheng Ruan, Ying Liu, Chengyun Yang, Dan Qian, Zhiquan He, Dan Wang, Deling Lu, Hongwei Zhang, Yan Deng Scientific Reports.2024;[Epub] CrossRef
A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria Adebanjo J. Adegbola, Omotade A. Ijarotimi, Akaninyene E. Ubom, Bukola A. Adesoji, Olajide E. Babalola, Emma F. Hocke, Helle Hansson, Andria Mousa, Oluseye O. Bolaji, Michael Alifrangis, Cally Roper Malaria Journal.2023;[Epub] CrossRef
Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds S. Maheen Abdul Rahman, Jasvinder Singh Bhatti, Suresh Thareja, Vikramdeep Monga European Journal of Medicinal Chemistry.2023; 259: 115699. CrossRef
First
Prev
